EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis

Longhao Cheng, Xiaoxue Wang, Aijun Liu, Ying Zhu, Hu Cheng, Jiangling Yu, Lili Gong, Honglin Liu, Guolin Shen, Lihong Liu

Acta Pharmaceutica Sinica B · 2024-08 · 14 (8) · 3493-3512

DOI: 10.1016/j.apsb.2024.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-08. Verfasst von Longhao Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Capital Medical University, Beijing 100029, China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amino acid metabolic remodeling is a hallmark of cancer, driving an increased nutritional demand for amino acids. Amino acids are pivotal for energetic regulation, biosynthetic support, and homeostatic maintenance to stimulate cancer progression. However, the role of phenylalanine in multiple myeloma (MM) remains unknown. Here, we demonstrate that phenylalanine levels in MM patients are decreased in plasma but elevated in bone marrow (BM) cells. After the treatment, phenylalanine levels increase in plasma and decrease in BM. This suggests that changes in phenylalanine have diagnostic value and that phenylalanine in the BM microenvironment is an essential source of nutrients for MM progression. The requirement for phenylalanine by MM cells exhibits a similar pattern. Inhibiting phenylalanine utilization suppresses MM cell growth and provides a synergistic effect with Bortezomib (BTZ) treatment in vitro and murine models. Mechanistically, phenylalanine deprivation induces excessive endoplasmic reticulum stress and leads to MM cell apoptosis through the ATF3-CHOP-DR5 pathway. Interference with ATF3 significantly affects phenylalanine deprivation therapy. In conclusion, we have identified phenylalanine metabolism as a characteristic feature of MM metabolic remodeling. Phenylalanine is necessary for MM proliferation, and its aberrant demand highlights the importance of low-phenylalanine diets as an adjuvant treatment for MM.

Schlagwörter

Stichwörter der Autor:innen

ATF3Amino acid metabolismApoptosisCancer therapyEndoplasmic reticulum stressMultiple myelomaNutrient deprivationPhenylalanine

Autor:innen und Institutionen

  • Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Capital Medical University, Beijing 100029, China.
  • Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
  • Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • Institute of Chemicals Safety, Chinese Academy of Inspection and Quarantine, Beijing 100020, China.

Zitieren

APA

Cheng, L., Wang, X., Liu, A., Zhu, Y., Cheng, H., Yu, J., Gong, L., Liu, H., Shen, G., & Liu, L. (2024). Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis. Acta Pharmaceutica Sinica B, 14(8), 3493-3512. https://doi.org/10.1016/j.apsb.2024.04.021

Vancouver

Cheng L, Wang X, Liu A, Zhu Y, Cheng H, Yu J, et al. Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis. Acta Pharmaceutica Sinica B. 2024;14(8):3493-3512. doi:10.1016/j.apsb.2024.04.021

BibTeX
@article{Cheng2024,
  author = {Cheng, Longhao and Wang, Xiaoxue and Liu, Aijun and Zhu, Ying and Cheng, Hu and Yu, Jiangling and Gong, Lili and Liu, Honglin and Shen, Guolin and Liu, Lihong},
  title = {Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {3493--3512},
  doi = {10.1016/j.apsb.2024.04.021}
}
Kostenlos starten →